Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Atovaquone attenuates experimental colitis by reducing neutrophil infiltration of colonic mucosa.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Atovaquone attenuates experimental colitis by reducing neutrophil infiltration of colonic mucosa.
Atovaquone attenuates experimental colitis by reducing neutrophil infiltration of colonic mucosa. Front Pharmacol. 2022; 13:1011115.
View in:
PubMed
authors with profiles
Stephen B. Hanauer